PHILADELPHIA – Vincent Lo Re III, MD, MSCE, FIDSA, an assistant professor of Infectious Disease in the Perelman School of Medicine at the University of Pennsylvania was honored with the 2016 HIV Medicine Association (HIVMA) Research Award for his significant contributions to the field of HIV medicine. The award was presented on Thursday, Oct. 27 as part of IDWeek 2016 in New Orleans.
“It is an honor to be recognized with the HIVMA Research Award,” Lo Re said. “This week is about advancing science and research in order to better understand and treat infectious diseases and I am humbled that my work can contribute to this larger effort in some way.”
The HIVMA Research Award, given out annually during IDWeek, recognizes researchers who have made outstanding contributions to HIV medicine in clinical or basic research early in their careers. Through research, Lo Re has advanced the understanding of hepatitis infection in HIV-infected patients. He developed new methods to identify liver-related outcomes – particularly decompensated cirrhosis, acute hepatic failure and hepatocellular carcinoma – which are used by researchers throughout North America. Clinicians and policymakers cite his findings to justify initiating HCV treatment in chronic HIV-infected patients even in the absence of advanced hepatic fibrosis or cirrhosis.
Dr. Lo Re has authored more than 50 articles published in peer-reviewed publications and has been a member of the Food and Drug Administration’s Antiviral Drugs Advisory Committee (now the Antimicrobial Drugs Advisory Committee) since 2014. He received numerous young investigator awards and other honors, including recognition as one of the Best Doctors in America several times.
For full awards descriptions, recipient biographies and past award winners please visit HIVMA.org/Awards_Recognition. HIVMA’s annual meeting, IDWeek 2016, takes place Oct. 26-30 at the Ernest N. Morial Convention Center in New Orleans. To learn more, visit IDWeek.org.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.